Bank of Montreal Can bought a new stake in Maximus Inc. (NYSE:MMS) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 242,850 shares of the company’s stock, valued at approximately $13,446,000.
A number of other institutional investors have also added to or reduced their stakes in the company. Goldman Sachs Group Inc. increased its position in Maximus by 67.5% in the first quarter. Goldman Sachs Group Inc. now owns 1,211,350 shares of the company’s stock valued at $63,765,000 after buying an additional 488,027 shares during the period. Makaira Partners LLC acquired a new position in Maximus during the first quarter valued at $23,251,000. Pembroke Management LTD increased its position in Maximus by 17.1% in the second quarter. Pembroke Management LTD now owns 632,618 shares of the company’s stock valued at $35,028,000 after buying an additional 92,400 shares during the period. BlackRock Institutional Trust Company N.A. increased its position in Maximus by 2.3% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 1,954,460 shares of the company’s stock valued at $102,883,000 after buying an additional 44,202 shares during the period. Finally, TimesSquare Capital Management LLC increased its position in Maximus by 4.2% in the first quarter. TimesSquare Capital Management LLC now owns 907,848 shares of the company’s stock valued at $47,789,000 after buying an additional 36,545 shares during the period. Hedge funds and other institutional investors own 99.00% of the company’s stock.
Maximus Inc. (NYSE:MMS) traded up 1.09% during midday trading on Friday, hitting $56.56. The stock had a trading volume of 286,477 shares. The company’s 50-day moving average price is $57.99 and its 200 day moving average price is $55.65. Maximus Inc. has a 12-month low of $45.15 and a 12-month high of $69.85. The stock has a market cap of $3.67 billion, a P/E ratio of 23.11 and a beta of 1.12.
Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.75 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.04. Maximus had a return on equity of 23.89% and a net margin of 6.91%. The business had revenue of $617.10 million for the quarter, compared to the consensus estimate of $625.62 million. During the same quarter in the previous year, the company posted $0.62 earnings per share. Maximus’s revenue for the quarter was up 7.8% compared to the same quarter last year. On average, equities research analysts predict that Maximus Inc. will post $2.65 earnings per share for the current fiscal year.
Several equities analysts recently weighed in on MMS shares. Zacks Investment Research downgraded Maximus from a “hold” rating to a “sell” rating in a research report on Wednesday, August 3rd. KeyCorp started coverage on Maximus in a research report on Thursday, June 30th. They set an “overweight” rating and a $63.00 target price on the stock. Finally, Maxim Group increased their target price on Maximus from $71.00 to $74.00 and gave the stock a “buy” rating in a research report on Thursday, August 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $63.00.
In other news, President Bruce Caswell sold 30,000 shares of Maximus stock in a transaction on Thursday, August 18th. The stock was sold at an average price of $58.98, for a total transaction of $1,769,400.00. Following the transaction, the president now owns 39,386 shares in the company, valued at $2,322,986.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Raymond B. Ruddy sold 18,000 shares of Maximus stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $60.00, for a total value of $1,080,000.00. Following the transaction, the director now owns 295,552 shares in the company, valued at approximately $17,733,120. The disclosure for this sale can be found here. Insiders own 3.60% of the company’s stock.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus Inc. (NYSE:MMS).
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.